SCHEMBL2015455

SCHEMBL2015455

O=C(OCl)c1ccccc1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
ALOX15 P16050 1/20 0.59
CES2 O00748 3/20 0.58
CES1 P23141 3/20 0.58
KMT2A Q03164 3/20 0.49
GAA P10253 1/20 0.48
MEN1 O00255 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
NPC1 O15118 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 1/20 0.46
ESR1 P03372 1/20 0.45
ESR2 Q92731 1/20 0.45
PTPN1 P18031 1/20 0.44
ERCC5 P28715 1/20 0.44
FEN1 P39748 1/20 0.44
BCHE P06276 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1119555 0.84 TSHR (0.50) ALDH1A1ALOX15CES2CES1TDP1
SCHEMBL8378855 0.82 CES2 (0.62) ALDH1A1ALOX15CES2CES1KMT2A
SCHEMBL6062757 0.82 CES2 (0.62) ALDH1A1ALOX15CES2CES1KMT2A
SCHEMBL3398637 0.82 CES2 (0.62) ALDH1A1ALOX15CES2CES1KMT2A
SCHEMBL28939755 0.81 TSHR (0.48) ALDH1A1ALOX15CES2CES1TDP1
SCHEMBL20599487 0.80 CES2 (0.60) ALDH1A1ALOX15CES2CES1KMT2A
SCHEMBL24288684 0.78 CES2 (0.58) ALDH1A1ALOX15CES2CES1KMT2A
SCHEMBL513707 0.78 KMT2A (0.67) ALDH1A1ALOX15CES2CES1KMT2A
SCHEMBL21681966 0.78 CES2 (0.58) ALDH1A1ALOX15CES2CES1KMT2A
SCHEMBL513706 0.78 CES2 (0.58) ALDH1A1ALOX15CES2CES1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3551633-A1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Leo Pharma A/S (DK) 2019-10-16 EP claimed
WO-2018108230-A1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS LEO PHARMA A/S (DK) 2018-06-21 WO claimed
EP-2855428-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN Genentech, Inc. (US) 2015-04-08 EP disclosed
WO-2014062938-A1 RORY MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-04-24 WO disclosed
WO-2013177224-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN GENENTECH, INC. (US) 2013-11-28 WO disclosed
EP-2513052-A1 PYRROLIDINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2012-10-24 EP disclosed
EP-2513084-A1 PYRROLIDINE DERIVATIVES AS NK - 3 RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2012-10-24 EP disclosed
WO-2011085886-A1 PYRROLIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-07-21 WO disclosed
WO-2011073160-A1 PYRROLIDINE DERIVATIVES AS NK - 3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-06-23 WO disclosed
US-7642358-B2 Substituted phenylacetic acids METABOLEX, INC. (US) 2010-01-05 US disclosed